Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...
1don MSN
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.
News Medical on MSN1d
Addressing COPD and metabolic syndrome requires comprehensive research effortsAdditional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.
The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...
News Medical on MSN4d
Study finds no clinical advantage of budesonide inhaler over fluticasone in COPDA study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...
New Study Shows Promising Results for COPD Treatment Nov. 20 ... Sep. 26, 2024 — What factors lead to chronic respiratory disease? Researchers investigated this question using health data ...
China approves GSK's Nucala for chronic rhinosinusitis with nasal polyps, adding to its existing uses in asthma and other ...
Company has also raised $12 million in funding led by Lucius Partners NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- AerWave Medical, a leader in ultrasound-based interventional pulmonary solutions, ...
Verona Pharma (VRNA) stock in focus as company reports early sales for Q4 and 2024 thanks to its lung disease therapy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback